X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (211) 211
Publication (33) 33
Newspaper Article (20) 20
Book / eBook (12) 12
Dissertation (3) 3
Book Chapter (2) 2
Web Resource (2) 2
Book Review (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
male (106) 106
oncology (106) 106
child (102) 102
female (100) 100
child, preschool (85) 85
adolescent (79) 79
infant (61) 61
pediatrics (61) 61
index medicus (59) 59
adult (52) 52
children (49) 49
cancer (34) 34
treatment outcome (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
hematology (29) 29
chemotherapy (28) 28
prognosis (26) 26
article (25) 25
neoplasms - drug therapy (25) 25
neuroblastoma (22) 22
surgery (22) 22
risk factors (21) 21
retrospective studies (17) 17
therapy (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
camptothecin - analogs & derivatives (16) 16
young adult (16) 16
colony-stimulating factor (13) 13
drug administration schedule (13) 13
irinotecan (13) 13
neuroblastoma - drug therapy (13) 13
patients (13) 13
care and treatment (12) 12
childhood (12) 12
combined modality therapy (12) 12
survival (12) 12
toxicity (12) 12
animals (11) 11
disease-free survival (11) 11
health aspects (11) 11
medicine & public health (11) 11
solid tumors (11) 11
survival rate (11) 11
antineoplastic agents - adverse effects (10) 10
cardiac & cardiovascular systems (10) 10
cell lung-cancer (10) 10
diagnosis (10) 10
dose-response relationship, drug (10) 10
middle aged (10) 10
survival analysis (10) 10
tumors (10) 10
antineoplastic agents - pharmacokinetics (9) 9
camptothecin - administration & dosage (9) 9
cisplatin (9) 9
infant, newborn (9) 9
neuroblastoma - pathology (9) 9
recurrence (9) 9
research (9) 9
aged (8) 8
antineoplastic agents - therapeutic use (8) 8
camptothecin - adverse effects (8) 8
camptothecin - pharmacokinetics (8) 8
complications (8) 8
infusions, intravenous (8) 8
neuro-blastoma (8) 8
pediatric-oncology-group (8) 8
pharmacology & pharmacy (8) 8
radiology, nuclear medicine & medical imaging (8) 8
tomography, x-ray computed (8) 8
topotecan (8) 8
abridged index medicus (7) 7
acute lymphoblastic-leukemia (7) 7
age factors (7) 7
antineoplastic agents - administration & dosage (7) 7
etoposide - administration & dosage (7) 7
every 3 weeks (7) 7
magnetic resonance imaging (7) 7
maximum tolerated dose (7) 7
metastatic colorectal-cancer (7) 7
mice (7) 7
neoplasm staging (7) 7
neuroblastoma - therapy (7) 7
patient outcomes (7) 7
pediatric oncology (7) 7
pharmacokinetics (7) 7
protracted irinotecan (7) 7
refractory solid tumors (7) 7
sarcoma (7) 7
trial (7) 7
administration, oral (6) 6
adolescents (6) 6
analysis (6) 6
antitumor-activity (6) 6
bone-marrow transplantation (6) 6
camptothecin - therapeutic use (6) 6
carboplatin (6) 6
chemotherapy, adjuvant (6) 6
clinical neurology (6) 6
combination (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (3) 3
Gerstein Science - Stacks (2) 2
Robarts - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 08/2009, Volume 50, Issue 8, pp. 1237 - 1243
The purpose of this study was to compare the diagnostic utility of I-123-metaiodobenzylguanidine (I-123-MIBG) scintigraphy and F-18-FDG PET in neuroblastoma.... 
FDG-PET/CT | COLONY-STIMULATING FACTOR | ATOMIC-BOMB SURVIVORS | MIBG | BONE-MARROW | neuroblastoma | FOLLOW-UP | I-123-MIBG | F-18-FDG PET | POSITRON-EMISSION-TOMOGRAPHY | PHEOCHROMOCYTOMA | NEURAL CREST TUMORS | UTILITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 14, pp. 1445 - 1452
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 36, pp. 9146 - 9154
Purpose: The viewpoint of the terminally ill child at the time of an end-of-life decision has not been formally investigated. We identified the preferences of... 
PHASE-I TRIALS | DECISION-MAKING | ONCOLOGY | ADOLESCENTS | PARENTS | SYMPTOMS | CHILDREN | PERCEPTIONS | Decision Making | Prognosis | Cross-Sectional Studies | Neoplasms - rehabilitation | Humans | Male | Altruism | Adolescent | Adult | Death | Female | Terminal Care | Parent-Child Relations | Child
Journal Article
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 05/2012, Volume 34, Issue 2, pp. S76 - S79
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6441 - 6449
Purpose: Anti-GD2 mAbs, acting via antibody-dependent cell-mediated cytotoxicity, may enhance the effects of chemotherapy. This pilot trial investigated a... 
INTERLEUKIN-2 | MELANOMA | SOLID TUMORS | REFRACTORY NEUROBLASTOMA | ONCOLOGY | PHASE-I TRIAL | CYCLOPHOSPHAMIDE | IMMUNOTHERAPY | RECURRENT | CELLULAR CYTOTOXICITY | PLUS | Drug-Related Side Effects and Adverse Reactions - blood | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neuroblastoma - blood | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Dacarbazine - analogs & derivatives | Killer Cells, Natural - immunology | Camptothecin - administration & dosage | Female | Child | Neoplasm Recurrence, Local - blood | Neuroblastoma - pathology | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - administration & dosage | Gangliosides - antagonists & inhibitors | Interleukin-2 Receptor alpha Subunit - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cell- and Tissue-Based Therapy | Gangliosides - immunology | Disease-Free Survival | Ifosfamide - administration & dosage | Neuroblastoma - drug therapy | Adolescent | Topotecan - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Interleukin-2 - blood | Toxicity | Cytotoxicity | Malignancy | Neuroblastoma | Cerebrospinal fluid | Pain | Interleukin 2 | Surgery | Myelosuppression | Children | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Thrombocytopenia | Immune response | Cytokines | Ifosfamide | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | Etoposide | Pharmacology | Patients | Irinotecan | Cyclophosphamide | Chemotherapy | Experimental design | Monoclonal antibodies | Carboplatin | Temozolomide | Pharmacokinetics | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3292 - 3298
Purpose Parents of children with incurable cancer make complex and difficult decisions about remaining treatment options. We compared the self-reported... 
OF-LIFE CARE | PALLIATIVE CARE | IMPACT | THERAPY | ONCOLOGY | PROGNOSIS | FAMILIES | GOALS | TALKING | Decision Making | Humans | Parents | Social Support | Neoplasms - mortality | Resuscitation Orders - psychology | Male | Neoplasms - psychology | Clinical Trials, Phase I as Topic - mortality | Neoplasms - therapy | Quality of Life | Adult | Female | Terminal Care | Parent-Child Relations | Child | Original Reports | Pedi23
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2019, Volume 20, Issue 5, pp. 719 - 727
Hepatoblastoma treatment with curative intent requires surgical resection, but only about a third of newly diagnosed patients with hepatoblastoma have... 
TUMOR | SURGICAL RESECTION | CISPLATIN | ONCOLOGY | DOXORUBICIN | Liver cancer | Adjuvant treatment | Cancer
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 12, pp. 2360 - 2367
Journal Article